Evaluation of Effective Clinicopathologic Factors on Patients Outcome with Well Differentiated Thyroid Carcinoma

Message:
Abstract:
Introduction
Thyroid cancer is the most common cancer of endocrine system. Clinical, pathological and therapeutic factors affected patients outcome with differentiated thyroid carcinoma.
Objective
To evaluation the effective clinicopathologic factors on patients outcome with well differentiated thyroid carcinoma.
Materials And Methods
In this retrospective analytic-descriptive study. Patients files with thyroid carcinoma who referred to radiology and oncology ward in Omid and Ghaem hospital of Mashhad were assessed from 1996-2006. Cases with pathologic report of papillary and follicular carcinoma were considered and a specific questionnaire include age, sex, accepted time, pathologic subtype, tumor size and metastases, adjuvant treatment, last follow time, recurrence time, patient condition in the end refer and death time was recorded.
Results
The patients mean age was 50.14 and median age was 52 years. 66 patients (85.7%) had papillary and 11 cases (14.3%) had follicular carcinoma. End condition in 43 cases (55.8%) was good and in 34 cases (44.2%) was bad. Mean survival time was 44.1 and median survival time was 36 months. There was a meaningful correlation between T stage with end condition (P=0.037) but there was no meaningful correlation between N stage with end condition (P=0.665). Metastases in the first reference time had a clear correlation with patients outcome. 41patients (59.4%) from 69 cases with MO disease had a good end condition, against only one patient (16.7%) from 6 cases with M1 had a good outcome
Language:
Persian
Published:
Journal Of Guilan University Of Medical Sciences, Volume:19 Issue: 74, 2010
Page:
9
magiran.com/p772975  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!